Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 20 Jul 2012 DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination – New formulation to fill the deadly gap in appropriate HIV medicines
Press releases 12 Jun 2012 Astellas and DNDi to Collaborate on New Drug Discovery Research for the Treatment of Neglected Tropical Diseases
Press releases 21 May 2012 Sustainable R&D Framework Needed to Address Essential Health Needs of Developing Countries
Press releases 24 Apr 2012 Cipla and DNDi announce the forthcoming launch of Artesunate + Mefloquine fixed-dose combination for P. falciparum malaria
Press releases 12 Apr 2012 AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases
Press releases 12 Mar 2012 DNDi Secures EUR 2 Million Strategic Translation Award from Wellcome Trust to Develop a New Drug against Chagas Disease
Press releases 12 Mar 2012 DNDi Launches Phase I In-Human Clinical Trial for Promising Oral Drug for Sleeping Sickness
Press releases 30 Jan 2012 DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases
Press releases 30 Jan 2012 Filling R&D Gaps Key to Succeeding in NTD Control and Elimination Goals by 2020
Press releases 30 Jan 2012 Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020
Press releases 23 Jan 2012 Germany’s Federal Ministry of Education and Research Grants EUR 8 Million to DNDi for the Development of New Treatments for Neglected Tropical Diseases
Press releases 23 Dec 2011 New treatment for kala azar, the most deadly parasitic disease after malaria
Press releases 1 Dec 2011 Children with HIV/AIDS Falling Through the Cracks of Treatment Scale-Up Efforts
